LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies

Abroad (travel likely)RecruitingPHASE1

Conditions

Non Hodgkin Lymphoma · Diffuse Large B Cell Lymphoma · Follicular Lymphoma · Marginal Zone Lymphoma · Mantle Cell Lymphoma · Burkitt Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Froedtert & the Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Contact: Study coordinator (Nirav Shah, MD) · nishah@mcw.edu · 414-805-4400

Study leads

Nirav Shah, MD
Principal Investigator
Medical College of Wisconsin

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

Follicular Lymphoma · Lymphoma

Abroad (travel likely)RecruitingPHASE2

Washington D.C., United States · Basking Ridge, United States

SynKIR-310 for Relapsed/Refractory B-NHL

B Cell Lymphoma · NHL, Adult · Mantle Cell Lymphoma

Abroad (travel likely)RecruitingPHASE1

Denver, United States · Atlanta, United States

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Chronic Lymphocytic Leukemia (CLL) · Small Lymphocytic Lymphoma (SLL) · Waldenstrom Macroglobulinemia (WM)

Abroad (travel likely)RecruitingPHASE1

Duarte, United States · Orange, United States

Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

Diffuse Large Cell Lymphoma · Non-Hodgkin Lymphoma · Burkitt Lymphoma

Abroad (travel likely)RecruitingPHASE1

Bethesda, United States